BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Policy

  Alkermes Release: Supplemental New Drug Application for RISPERDAL(R) CONSTA(R) Submitted to the FDA for the Treatment of Frequently Relapsing Bipolar Disorder

  April 14, 2008

   · 

  1 min read
• BioCapital

  Calibrant Biosystems Announces Gemini(TM) Drug Discovery and Development Presentations at 2008 American Association for Cancer Research Annual Meeting

  April 14, 2008

   · 

  1 min read
• Genetown

  Novelos Therapeutics, Inc. Closes $5.7 Million Private Placement

  April 14, 2008

   · 

  1 min read
• Pharm Country

  Callisto Pharmaceuticals Receives Notice of Delisting From AMEX - Subject to Appeal

  April 14, 2008

   · 

  1 min read
• EBD Group Relesae: BIO-Europe Spring(R) 2008 Facilitates Biotech-Pharma Partnering on an Impressive Scale

  April 14, 2008

   · 

  1 min read
• Drug Development

  U3 Pharma Achieves Preclinical Proof of Concept for U3-1287 (AMG 888)

  April 14, 2008

   · 

  1 min read
• Drug Development

  Introgen Therapeutics, Inc. Release: New Phase III Data Confirm Phase II Findings of ADVEXIN(R) Efficacy

  April 14, 2008

   · 

  1 min read
• Drug Development

  Early Data on Amgen’s Anti-Angiogenesis Pipeline Molecules Suggest Biologic Activity Across Tumor Types

  April 14, 2008

   · 

  1 min read
• Drug Development

  Medgenics, Inc. on Target to Start Phase I/II Clinical Trials With EPODURE Protein Therapy for Anaemia Mid-2008 as Planned

  April 14, 2008

   · 

  1 min read
• Business

  Sequenom Inc. to Hold 2008 First Quarter Financial Results Conference Call on April 30

  April 14, 2008

   · 

  1 min read